StonvexLoading…
StonvexStonvexStonvexCore line items from NSIT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.13B | $8.25B | $6.20B | $4.20B |
Operating Income | $71.68M | $334.92M | $239.70M | $146.63M |
Net Income | $30.01M | $157.35M | $105.39M | $54.45M |
EPS (Diluted) | $0.97 | $4.86 | $3.22 | $1.63 |
Total Assets | $10.06B | $9.09B | $8.90B | $8.73B |
Total Liabilities | $8.45B | $7.44B | $7.32B | $7.12B |
Cash & Equivalents | $440.63M | $358.02M | $547.02M | $309.13M |
Free Cash Flow OCF − CapEx | $26.39M | $279.31M | $132.51M | $-110.98M |
Shares Outstanding | 30.19M | 31.00M | 30.97M | 31.42M |